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Abstract 
Post-stroke dysphagia (PSD) is present in more than 50 % of acute stroke patients, increases 
the risk of complications, in particular aspiration pneumonia, malnutrition and dehydration, 
and is linked to poor outcome and mortality. The aim of this guideline is to assist all 
members of the multidisciplinary team in their management of patients with PSD. These 
guidelines were developed based on the European Stroke Organisation (ESO) standard 
operating procedure and followed the Grading of Recommendations, Assessment, 
Development, and Evaluation (GRADE) approach. An interdisciplinary working group 
identified 20 relevant questions, performed systematic reviews and meta-analyses of the 
literature, assessed the quality of the available evidence, and wrote evidence-based 
recommendations. Expert opinion was provided if not enough evidence was available to 
provide recommendations based on the GRADE approach. We found moderate quality of 
evidence to recommend dysphagia screening in all stroke patients to prevent post-stroke 
pneumonia and decrease risk of early mortality and low quality of evidence to suggest 
dysphagia assessment in stroke patients having been identified at being at risk of PSD. We 
found low to moderate quality of evidence for a variety of treatment options to improve 
swallowing physiology and swallowing safety. These options include dietary interventions, 
behavioral swallowing treatment including acupuncture, nutritional interventions, oral 
health care, different pharmacological agents and different types of neurostimulation 
treatment. Some of the studied interventions also had an impact on other clinical endpoints 
such as feedings status or pneumonia. Overall, further randomised trials are needed to 
improve the quality of evidence for the treatment of PSD.  
  
Introduction 
The oropharyngeal swallow involves a rapid, highly coordinated set of neuromuscular actions 
beginning with lip closure and terminating with upper oesophageal sphincter closure when 
the bolus has passed through. The central coordination of this complex sensorimotor task uses 
a widespread network of cortical, subcortical, and brainstem structures 1, 2. Stroke is the most 
frequent disease leading to disruption of this swallowing network thereby causing an 
impairment of deglutition, i.e. post-stroke dysphagia (PSD) 3-5. Depending on the diagnostic 
criteria, timing and method of assessment, alongside stroke features, PSD is found in 29 to 
81% of acute stroke patients 6. Although many stroke patients recover swallowing within the 
first weeks after the ictus, 11–50% still suffer from dysphagia at six months 7, 8. PSD broadly 
affects swallowing safety leading to an increased risk of aspiration and subsequent 
pneumonia, and swallowing efficacy with the related danger of insufficient nutrition and 
hydration. Apart from these physical consequences, dysphagia has a significant impact on the 
psychological well-being and level of independence for the affected individuals and dysphagia 
has been linked to low mood and depression 9. 
Because of its large epidemiological burden and hazardous clinical complications, the 
European Stroke Organization (ESO) and the European Society for Swallowing Disorders 
(ESSD) have decided to compile guidelines on the management of PSD. These 
recommendations are based on findings from randomized controlled trials (RCTs) and 
observational studies. They were agreed through consensus with the involved authors using 
the grading of recommendations assessment, development and evaluation (GRADE) approach 
and the ESO standard operating procedure (SOP) for guidelines development 10 and have the 
approval of the ESO Executive Committee. 
The aim of this guideline document is to inform physicians, speech-and-language therapists 
(SLTs) as well as stroke-nurses, and all the members of the multidisciplinary team on how to 
screen, assess and treat patients with PSD to avoid dysphagia-related complications and to 
facilitate recovery of swallowing function.  
Methods 
Three group leaders, two SLTs (EM and MT) and one neurologist (RD) from three European 
countries with expertise in PSD were nominated by the Guideline Committee of the ESO. 
These three group leaders suggested a group of 11 experts covering a broad spectrum of 
medical professions involved in dysphagia care, in particular two SLTs (MW, SP), a 
phoniatrician (AS), a surgeon (PC), two neurologists (MA, JG), a geriatrician (RW), a 
gastroenterologist (SH), a stroke physician (PMB), a pharmacist (DW), and a rehabilitation 
physician (EV) from 7 European countries. The guideline team was completed by a guideline 
methodologist (AL). Seven members of the ESSD board were among the authors (RD, SH, PC, 
EV, AS, EM, MW). Due to the European-wide approach, stakeholders in terms of the target 
patient population were not included in this guideline project. The working group (WG) was 
confirmed by the ESO Executive Committee. Standardised steps which were undertaken by 
the WG are summarised as follows: 
(1) The group discussed and decided by consensus on specific and clinically relevant patient, 
intervention, comparator, outcome (PICO) questions.  
(2) The group identified all important outcomes for the PICO questions (Table 1). 
(3) The group identified all available publications published in English related to the PICO 
questions in 4 separate searches. These were guided by the 2011 Centre for Evidence Based 
Medicine’s levels of evidence 11. We searched the databases such as MEDLINE, EMBASE, 
CINAHL and Cochrane database of systematic reviews (CDSR), the Cochrane central register 
of controlled trials (CENTRAL) (1990 through August 2018). Furthermore, we searched the 
reference lists of review articles and clinical trials on PSD for further appropriate studies. 
(4) The group selected eligible studies. Due to the high number of PICO questions different 
WG members were responsible for the 4 separate topics and screened the respective 
articles. As we identified relatively few RCTs and systematic reviews or meta-analyses of 
RCTs, we also included observational and epidemiological studies that might facilitate the 
recommendations or proposals (supplement 1). 
(5) Meta-analysis was performed using the Review Manager (RevMan, version 5.3) Cochrane 
Collaboration software. The risk ratios (RRs), odds ratios (ORs), mean difference (MD) or 
standard mean difference (SMD) and 95% confidence intervals (CIs) were calculated, with a 
random effects model, for all outcomes, were calculated12. Where appropriate, subgroup 
analyses based on different treatment modalities within a given main category were 
performed. Results were then summarised in GRADE evidence profiles and summary of 
findings tables. Directness refers to the extent by which patient populations, interventions 
and outcomes are similar to those of interest.  
The Cochrane Collaboration’s tool was used to perform the assessment of Risk of bias of 
RCT. The various components of this tool, such as risk of selection (randomization, allocation 
concealment), performance (blinding of participants and personal), detection (blinding of 
outcome assessment), attrition (incomplete outcome data), and reporting (selective 
reporting) bias were assessed in each RCT13. For NRCTs the different components of the 
SIGN-checklist such as conduct of study, selection of subjects, assessment, confounding the 
statistical analysis were using the Scottish Intercollegiate Guidelines Network (SIGN) 
checklist (https://www.sign.ac.uk/what-we-do/methodology/checklists/). 
(6) The components of GRADE system such as, Study design, Risk of bias, Inconsistency, 
Indirectness, Imprecision, and other considerations were considered in grading the evidence. 
The study design specified the basic design of the study (RCT or non-RCT). The Risk of bias 
assessed if there was any limitation in the rating the RCT or non-RCT. Study Heterogeneity 
across studies was assessed using Cochran’s Q (reported as a p value) and I2 statistics. 
I2 statistic, an expression of inconsistency of studies’ results describes the percentage of 
variation across studies due to heterogeneity rather than by chance was calculated.  A high 
value of I2 (>50%) and p value <0.05 indicate statistically significant heterogeneity among the 
studies for an outcome. Indirectness assessed if the evidence answered the PICO question 
directly or there was indirectness in the available evidence. Directness refers to the extent 
by which patient populations, interventions, comparator, outcomes and study design are 
similar to those of our PICO question. Imprecision assessed the preciseness of overall results 
of the evidence (from meta-analysis or study). The other considerations assessed publication 
bias, effect size, residual confounding and dose effect gradient. The Funnel plots were 
performed if 10 or more studies reported the data of an outcome and their shape was 
visualized for symmetry. An asymmetry of the funnel plot (with ≥ 10 studies) or less than 10 
studies for a meta-analysis for an outcome indicated publication bias.  If there was any 
limitation in the risk of bias, heterogeneity, directness, imprecision or publication bias, the 
certainty of the evidence was downgraded. The certainty of the grade-evidence was 
upgraded if the effect size of the evidence was large (e.g., RR/OR > 2 or <0.5), studies 
reported the data of residual confounding, or studies reported data on dose effect gradient. 
For each PICO question and each outcome, the quality of evidence was rated using the 
GRADEpro Guideline Development Tool (McMaster University, 2015; developed by Evidence 
Prime, Inc.) as high, moderate, low or very low (see box 1). 
(7) The final summaries of the quality and strength of evidence and recommendations for 
each PICO question were discussed by the whole group, recommendations were agreed on 
by the authors14. The strength of recommendations was graded as strong when the desirable 
effect of an intervention clearly outweighed the undesirable effects or clearly did not, or 
weak when the trade-off was less certain, either because of low-quality evidence, or because 
the evidence suggested that desirable and undesirable effects were more closely balanced 
(Box 2).  
(8) This guideline document was subsequently reviewed several times by all MWG and 
modified until a consensus was reached.  
(9) Finally, the Guideline document was reviewed and approved by five external reviewers, 
the ESO Guidelines board and the ESO Executive committee.  
(10) The WGs who completed this guideline will be reviewing the evidence on a regular 
basis, with the first anticipated partial review in 2024. We envisage that this period after the 
publication of these guidelines will further increase the number of clinical studies published 





Part 1: Impact of PSD on stroke outcome 
The working group formulated one introductory research question. 
1. In patients with acute and /or subacute stroke, does presence of dysphagia compared to 
no dysphagia have an effect on functional outcome and/or survival, aspiration risk, length 
of hospital stay, adverse events and complications, nutritional status, or quality of life? 
Out of a total of 1867 studies the literature search revealed 43 prospective or retrospective 
studies that addressed one or more of the mentioned endpoints 7, 15-57. Each outcome was 
assessed in a separate meta-analysis (Table 2, supplement 2). As evidenced by these 
analyses, there is a high probability that PSD has a considerable impact on nearly all of the 
mentioned outcomes. In particular, PSD was associated with an increased 12-months-
mortality (OR 8.82 [3.56, 21.85]), poorer outcomes (mRS 4-5) (OR 5.03 [4.43, 5.72]), 
pneumonia (OR 7.45 [6.01, 9.24]), insertion of a percutaneous endoscopic gastrostomy 
(PEG)-feeding tube (OR 71.60 [34.38, 149.11]), hospital length-of-stay (OR 4.72 [3.53, 5.91]), 
and discharge to institutional care (OR 3.90 [2.93, 5.21]).  
The most recent study and also the one with the biggest impact on the meta-analyses 
scrutinised registry data from 6677 stroke patients 37. Failing dysphagia screening was 
associated with poor outcomes, including pneumonia (adjusted OR 4.71 [3.43, 6.47]), severe 
disability (adjusted OR 5.19 [4.48, 6.02]), discharge to long-term care (adjusted OR 2.79 
[2.11, 3.79]), and 1-year mortality (adjusted hazard ratio, 2.42; [2.09, 2.80]). Aiming at 
developing a tool to predict pneumonia post stroke, Hoffmann and co-workers analysed 
registry data from 15335 patients 34. Adjusted for other predictors such as age and stroke 
severity, dysphagia was associated with an OR of 2.64 [2.21, 3.15] to develop pneumonia. 
Consequently, the 10-point score (A2DS2) proposed by the authors attributed two points to 
the presence of PSD (Age ≥75 years = 1 pt., Atrial fibrillation = 1 pt., Dysphagia = 2 pts., male 
Sex = 1 pt., stroke Severity, National Institutes of Health Stroke Scale 0–4 = 0, 5–15 = 3, ≥ 16 
= 5 pts.). 
Conclusion: In patients with acute and /or subacute stroke, the presence of dysphagia has 
an adverse effect on functional outcome and mortality, increases the risk of pneumonia, 
malnutrition, PEG-feeding, and discharge to institutional care and prolongs hospital 
length-of-stay. Quality of evidence: Moderate (Expert consensus). 
 
  
Part 2: Dysphagia and nutritional screening 
Dysphagia screening 
Due to the impact of PSD on specific complications and global outcome post stroke, many 
hospitals globally use dysphagia screening protocols to identify patients at risk of aspiration 
and to guide subsequent diagnostic and therapeutic procedures. In addition, dysphagia 
screening has also been implemented in various guidelines 58-62 and is part of auditing 
systems for stroke units 63.  
This guideline does not review evidence for the accuracy and reliability of different 
dysphagia screening protocols compared with gold standard assessments, in particular the 
Videofluoroscopic Swallowing Study (VFSS) and Flexible Endoscopic Evaluation of Swallowing 
(FEES). This has previously been done in different reviews 64-70 that generally favoured one or 
the other specific protocol but did not provide “the optimal screening protocol” due to a lack 
of sufficient comparative studies. In the main, the widely used water swallow tests (WST) 
usually expose the patient to drinking a predefined volume of water (for example 50 or 90 
ml). Where clinical aspiration signs (cough, voice change, stridor) occur during or after the 
screening, the test is considered positive and the patient is kept nil-by-mouth and more 
sophisticated diagnostic procedures are initiated. If the patient passes the test, oral feeding 
is recommended. Apart from WSTs, multiple consistency tests have also been proposed (see 
PICO 3 in this chapter). 
The WG formulated three PICO questions. Because these questions are closely intertwined 
an overall conclusion is given at the end of this section after the third PICO question has 
been discussed. 
1. In patients with acute stroke does screening compared to no screening for dysphagia 
improve functional outcome and/or survival, reduce aspiration risk, reduce length of 
hospital stay, reduce adverse events and complications, have an effect on nutritional 
status, and have an effect on quality-of-life? 
Out of 3084 titles our search resulted in 13 studies with data pertinent to this question 15, 40, 
47, 71-80 (Table 3, supplement 3). As revealed by the meta-analysis, dysphagia screening for 
PSD was related to a reduced risk of pneumonia (OR 0.55 [0.36, 0.83]) and there was a trend 
for reduced mortality during acute care associated with dysphagia screening (OR 0.67 [0.45, 
1.02], p=0.06). Dysphagia screening was not related to 1-month mortality, length-of-stay or 
discharge destination. Quality of evidence was low since there were no randomized trials 
available. Most data were obtained either from cohort-studies or from studies comparing 
‘pre-post-scenarios’. Thus, for example, Hinchey et al. compared the incidence of pneumonia 
post stroke in hospitals providing a formalized dysphagia screen versus incidence rates from 
hospitals not-providing screening. In their study, the use of a formal protocol performed on 
all stroke admissions decreased the risk of pneumonia by 3-fold 72. More recently, Titsworth 
and co-workers adopted a ‘prospective interrupted time-series trial’ to evaluate the effect of 
implementing a dysphagia protocol with a nurse-administered bedside dysphagia screen and 
a rapid clinical swallow evaluation by a SLT. Their main findings were that adherence to 
dysphagia screening nearly doubled (39.3% to 74.2 %) and incidence of pneumonia was 
more than halved (6.5% to 2.8%) after protocol implementation 77.  
 
2. In patients with acute stroke, does early dysphagia screening compared to no screening 
or late screening, improve functional outcome and/or survival, reduce aspiration risk, 
length of hospital stay, adverse events and complications and have an effect on nutritional 
status and on quality of life? 
Based on the same search as for PICO 1 above 13 studies were analysed 15, 74, 80-90 (Table 4, 
supplement 3). Meta-analysis revealed that early screening for PSD was related to a reduced 
mortality at different points in time (acute hospital stay (OR 0.74 [0.61, 0.89], 1 year (0R 0.94 
[0.90, 0.97]), whereas there was a trend for reduced mortality at 1 months (OR 0.66 [0.42, 
1.02]) and 6 months (OR 0.51 [0.26, 1.03]).  
Most studies available concerning this PICO question addressed the issue of pneumonia. 
Here, a significant reduction in pneumonia risk (9% vs. 15%) related to early dysphagia 
screening was identified by the meta-analysis summarising the evidence from 10 studies and 
96367 patients (OR 0.45 [0.35, 0.58]). Finally, early dysphagia screening was also associated 
with a reduced LOS (MD -2.27 [-3.12, -1.43]), whereas all other endpoints had too few 
studies to provide reliable conclusions based on further meta-analyses. As already 
mentioned above, quality of evidence was generally low, because no randomized-controlled 
trials have been conducted in this area. The two most influential studies with regards to this 
PICO question were derived from prospective stroke registries based on comparatively large 
cohorts. Based on the analysis of 12276 patients, Al-Khaled et al. found that dysphagia 
screening within 24 hours after admission was independently associated with a reduced risk 
of pneumonia (OR 0.68 [0.52, 0.89]) and disability at discharge (OR 0.60 [0.46, 0.77]) when 
compared to no or later screening 15. Bray and co-workers analysed data from 63500 acute 
stroke patients 74. Dysphagia screening was performed 2.9 hours (median [IQR 1.3–5.7h]) 
after admission and the incidence of pneumonia was 8.7%. One of this study’s main findings 
was an association between delays in dysphagia screening and incidence of pneumonia with 
patients with the longest delays in screening (fourth quartile, ≥345 minutes delay) having 
36% higher odds of pneumonia as compared to those in the first quartile (0-79 minutes 
delay). 
 
3. In patients with acute stroke does dysphagia screening with multiple consistencies 
compared to screening with single consistencies improve functional outcome and/or 
survival, reduce aspiration risk, length of hospital stay, adverse events and complications, 
and have an effect on nutritional status and/or quality of life? 
Apart from water-screening tests, which are the most commonly used methods to screen for 
dysphagia in acute stroke and which provide a binary test results (i.e. fail or pass), there are 
also screening tests available that use more than one consistency for screening. These multi-
consistency-tests therefore allow for a graded stepwise rating of swallowing impairment and 
usually add dietary recommendations to their risk assessments. Thus, the Gugging 
Swallowing Screen (GUSS) sequentially evaluates the patient’s ability to swallow semisolid, 
liquid and solid boluses of increasing volumes. The test is terminated if clinical aspiration 
signs are observed. As a result of this test, dysphagia is graded into one of four categories 
(severe, moderate, mild or no dysphagia) and for each severity level a special diet and 
further strategies are recommended 82, 91, 92. Similar to this approach, the volume-viscosity 
swallow test (V-VST) evaluates boluses of different volumes (5, 10, 20 ml) and viscosities 
(nectar-like, thin liquid, extreme spoon-thick) following a defined algorithm. In addition to 
swallowing safety (clinical aspiration signs) swallowing efficacy is also established (oral 
residue, piecemeal deglutition) 93-95. In spite of the methodological differences between 
water-swallow-tests and multiple-consistency-tests, there are to date no comparative 
studies that help to determine which approach might work better in the context of stroke. 
Therefore, no specific recommendation with regards to this PICO question could be made. 
Recommendation 1: In all patients with acute stroke, we recommend a formal dysphagia 
screening test to prevent post-stroke pneumonia and decrease risk of early mortality. We 
recommend to screen the patients as fast as possible after admission.  For screening, 
either water-swallow-tests or multiple consistency tests may be used.  
Quality of evidence: Moderate ⊕⊕⊕ 
Strength of recommendation: Strong for intervention ↑↑ 
 
Recommendation 2: In patients with acute stroke, we recommend no administration of 
any food or liquid items, including oral medication, until a dysphagia screening has been 
done and swallowing was judged to be safe.  
Quality of evidence: Moderate ⊕⊕⊕ 
Strength of recommendation: Strong for intervention ↑↑ 
 
Although the scientific quality of the single studies included in the mentioned meta-analyses 
was mostly judged to be low with risk of bias, the authors decided, in line with the ESO-
guideline standard operation procedure, to upgrade the summary rating of the quality of 
evidence because study results were generally consistent and the association between early 
screening and the respective complications was at least in part strong (OR <0.5) or even very 
strong (OR < 0.2) as shown in the separate meta-analyses 10. In addition, the authors decided 
to upgrade the strength of recommendation because the risk of the intervention (dysphagia 
screening) is judged to be very low so that its potential benefit clearly outweighs the 
associated risk of harm 10. 
 
Nutritional screening 
Malnutrition is present in about one quarter of stroke patients with studies reporting 
prevalence between 6 and 62% depending on the timing of assessment, patients’ 
characteristics, and methods used 96. Commonly patients will present with malnutrition on 
admission, while in others malnutrition develops during the further course of the disease 97-
99. Malnutrition has been shown to be associated with an excess in mortality, bad functional 
outcome, prolonged length of stay in hospital and increased healthcare costs 60, 100-102. The 
aetiology of malnutrition in the context of stroke is heterogeneous and includes, apart from 
dysphagia, functional disability, impaired consciousness, perception deficits, cognitive 
dysfunction and depression 103.  
The working-group formulated one PICO question. 
1. In patients with post-stroke dysphagia does nutritional screening/assessment compared 
to no nutritional screening/assessment improve functional outcome and/or survival, 
reduce aspiration risk, reduce length of hospital stay, reduce adverse events and 
complications, improve swallowing status/function, have an effect on nutritional status, 
and have an effect on quality of life? 
Our literature search did not find any comparative studies pertinent to this question. 
However, with regards to the applicability in the clinical routine the Nutritional Risk 
Screening (NRS 2002) 104 and the Malnutrition Universal Screening Tool (MUST) 105 are 
proposed by two different guidelines 59, 60 and have been used extensively in stroke patients 
in prospective cohort studies 100, 106, 107.  
Therefore, the authors agreed on the following expert opinion that takes into account the 
recommendation of two guidelines dedicated to the topic of nutrition59, 60. 
Expert opinion:  There is consensus among the guideline group (15/15) that patients with 
acute stroke should be screened for nutritional risk within the first days after hospital 
admission using validated screening tools.  
 
  
Part 3: Dysphagia Assessment 
In contrast to aspiration screening, dysphagia assessment provides a more comprehensive 
picture about the specific swallowing impairment. Therefore, any dysphagia assessment 
usually offers a graded evaluation of dysphagia severity, incorporates recommendations 
targeting protective and rehabilitative strategies and allows for a monitoring of the patient’s 
swallowing ability during the further clinical course 59.  
In the context of stroke, dysphagia assessment is usually based on a clinical swallow 
examination (CSE) and/or VFSS or FEES. In brief, the CSE involves an examination of the oral 
cavity and the caudal cranial nerves. Subsequently, different food items are tested, and, in 
case of abnormal findings, manoeuvres are introduced to improve swallowing safety and 
efficacy. For documentation and interpretation of these evaluations different protocols are 
available 108, 109. Although CSE is widely used in the clinical context, its validity has been 
questioned frequently 110-113. Therefore, additional procedures, such as cough reflex testing, 
swallow-provocation test or peak-flow measurement have been introduced to assess, in 
particular, aspiration risk and risk of pneumonia 114-117. VFSS dynamically visualizes the oral, 
pharyngeal and oesophageal phases of swallowing. VFSS provides a comprehensive 
assessment of swallowing, determining not only whether the patient is aspirating but also 
why. Furthermore, it allows for experimentation with different textures, postures and 
manoeuvres suggested to improve the safety and efficiency of the swallow 118. Apart from 
determining specific parameters like “oral transit time”, “pharyngeal transit time” or 
“laryngeal vestibule closure time” 119-121, VFSS also allows for a global rating of swallowing 
function by aggregating a number of single items to a sum score. To this end, the Modified 
Barium Swallow Study Impairment Profile (MBSImP©™) 122, which results from combined 
rating of 17 parameters, has been introduced into practice and received first clinical testing 
123. FEES is an instrumental assessment of swallowing using a flexible nasolaryngoscope 
which is passed through the nares, over the velum into the pharynx. FEES is used to assess 
the pharyngeal swallow and to derive indirect signs of impairments of the oral and 
oesophageal stages of deglutition 124. The merits of FEES are that (i) it can be performed at 
the bedside, thus facilitating examination of severely motor-impaired, bedridden or 
uncooperative patients; (ii) follow-up examinations can be performed at short notice and, if 
necessary, frequently; (iii) oropharyngeal secretion management and efficacy of clearing 
mechanisms, such as coughing and throat clearing, can be assessed simply and directly; and 
(iv) pharyngeal sensation can be directly tested 125. 
In addition to the PICO questions and related conclusions given below, this guideline adopts 
the following recommendations from other guidelines because of its clinical impact. 
1. Following the suggestion of other guidelines 59, 60, stroke patients should be subjected 
to a dysphagia assessment if they have failed the dysphagia screen. Regardless of the 
outcome of the initial screening, a dysphagia assessment is also recommended in 
patients presenting with pertinent clinical risk factors for PSD or its complications, in 
particular severe dysarthria, aphasia, facial palsy, cognitive impairments and 
increased stroke severity (NIH-SS ≥ 10 points) 26, 36, 126-131. 
2. Taking into account the conclusion of a review focused on pharmacotherapy and 
dysphagia 132 and a recent guideline on neurogenic dysphagia 133 pill swallowing 
should be routinely evaluated as part of dysphagia assessment. Taking oral 
medication, especially swallowing tablets, is difficult for many patients with 
dysphagia. In addition to aspiration and the resulting complications and 
discontinuation of medication, unsuitable modification of the oral medication can 
often be observed (e.g. crushing, breaking, and opening of tablets and capsules), 
which may lead to numerous problems, such as decreased accuracy of dose, 
increased toxicity, reduced stability, and alteration of pharmacokinetics 134. 
Therefore, in stroke patients who are usually required to take oral medication,  
swallowing of tablets should be routinely evaluated and the optimal formulation (if 
available) should be identified 132.  
The working group formulated 6 PICO questions. Because these questions are closely 
related, an overall conclusion is given at the end of this section after the sixth PICO question 
has been discussed. 
1. In patients with acute and/or subacute stroke does full clinical and instrumental 
assessment compared to no assessment improve functional outcome and/or survival, 
reduce aspiration risk, reduce length of hospital stay, reduce adverse events and 
complications, have an effect on nutritional status, and/or have an effect on quality of 
life? 
Out of 5574 items our literature search resulted in no studies with data pertinent to this 
question. 
2. In patients with acute and /or subacute stroke does early assessment for dysphagia 
compared to late assessment improve functional outcome and/or survival, reduce 
aspiration risk, reduce length of hospital stay, reduce adverse events and complications, 
have an effect on nutritional status, and/or have an effect on quality of life? 
Based on the same search as for PICO 1 in this section, we detected 2 NRCTs that addressed 
this question 74, 85. In a multicentre prospective cohort study CSE was done in 38.6% of 63 
650 acute stroke patients after a median time of 22.9 hours (IQR 6.2–49.4 hours) after 
admission 74. The authors found a strong independent relationship between delay in 
dysphagia assessment and incidence of pneumonia. Delays in SLT assessment were 
associated with an absolute increase in the risk of pneumonia of 3% over the first 24 h. 
Delays in CSE beyond 24 h were associated with an additional 4% absolute increase in 
pneumonia. Dhufaigh and co-workers showed in a retrospective chart review that stroke 
patients receiving clinical dysphagia assessment within 48 hours after admission had 
significant fewer respiratory tract infections than patients seen thereafter 85. 
3. In patients with acute and /or subacute stroke do repeated assessments compared to 
single assessments improve functional outcome and/or survival, reduce aspiration risk, 
reduce length of hospital stay, reduce adverse events and complications, have an effect on 
nutritional status, and/or have an effect on quality of life? 
Based on the same search as for PICO 1 in this section we did not find any study pertinent to 
this question. 
4. In patients with stroke does clinical bedside assessment compared to instrumental 
assessment improve functional outcome and/or survival, reduce aspiration risk, reduce 
length of hospital stay, reduce adverse events and complications, have an effect on 
nutritional status, and/or have an effect on quality of life? 
Based on the same search as for PICO 1 in this section we found 2 NRCTs pertinent to this 
question 135, 136. Bax and co-workers showed in a pre-post-comparison that after 
implementation of a FEES-service nearly 40% of stroke patients were assessed with this tool 
as opposed to 6.4% before 135. In conjunction with this, the mean time to investigation 
decreased from 10.5 days to 2.3 days. With regards to clinical endpoints, after improving 
access to FEES, pneumonia rate significantly dropped from 12.3% to 6.4% (OR 2.06 [1.05, 
4.04]) and the proportion of patients being on a normal diet at discharge significantly 
increased from 51.1% to 65.6% (0.47 [0.31, 0.71]), while length-of-stay (LOS) in hospital also 
significantly increased from 15.2 to 20.2 days (Table 5, supplement 4) 135. Radhakrishnan et 
al. recruited a small cohort of tube-fed chronic stroke patients and showed that FEES and 
CSE substantially varied with regards to both rating of dysphagia severity and suggested 
feeding strategy 136.  
In addition to these two studies, three additional trials, which were methodologically not 
suitable for inclusion in this meta-analysis, should briefly be addressed here. The benefit of 
using FEES in acute stroke patients in addition to CSE has been explored in a recent 
prospective observational study recruiting 152 acute stroke patients with FEES having been 
performed in median 6 days after admission 137. Amongst other issues this study investigated 
whether the feeding strategy determined by the CSE was found to be appropriate when 
compared to FEES. Remarkably, FEES confirmed the chosen feeding strategy in less than one 
third of patients, but no information regarding health outcomes was collected. Based on 
FEES results 31.6% of patients needed a more restricted diet, while in 37.5% a more liberal 
diet was possible 137. The multicentre FEES-registry study, that recruited 2401 patients with 
different neurological diseases with stroke being the most frequent one (61%), 
demonstrated a comparable result 138. VFSS has been employed in a retrospective 
observational study that also focused on feeding strategy 139. In that study VFSS was done 
close to two weeks post stroke and only tube-fed patients were recruited. Removal of the 
nasogastric tube and start of an oral diet was suggested by VFSS in 199 out of 499 patients. 
During follow-up only 5 patients developed pneumonia, showing that swallowing safety had 
adequately been assessed by VFSS 139. 
5. In patients with acute and/or subacute stroke does instrumental assessment with VFSS 
compared to FEES improve functional outcome and/or survival, reduce aspiration risk, 
reduce length of hospital stay, reduce adverse events and complications, have an effect on 
nutritional status, and/or have an effect on quality of life?  
Based on the same search as above, we found one study related to this topic. Aviv 
randomized 126 dysphagic patients seen in an outpatient setting to receive either VFSS or 
FEES for swallowing evaluation to guide dysphagia management 140. Primary endpoint was 
pneumonia during follow-up. Chronic stroke represented the largest subgroup in this study 
(N=45). Pneumonia was diagnosed more frequently in stroke patients managed with VFSS (7 
out of 24) than with FEES (1 out of 21) (OR 8.24 [0.92, 73.79]), however this difference was 
not significant (p=0.06) (Table 6, supplement 4).   
6. In patients with acute and / or subacute stroke do complementary assessments to 
clinical assessments (i.e. spirometry, EMG) compared to standard clinical assessment 
improve functional outcome and/or survival, reduce aspiration risk, reduce length of 
hospital stay, reduce adverse events and complications, have an effect on nutritional 
status, and/or have an effect on quality of life? 
Based on the same search as above, we found one study pertinent to this topic. Miles and 
co-workers evaluated whether the implementation of cough reflex testing reduces 
pneumonia incidence and other outcomes in a cohort of acute stroke patients 141. In a 
multicenter randomized controlled trial with a follow-up period of 3 months 312 patients 
were randomized to either CSE alone or CSE plus cough reflex testing. This study did not find 
significant differences between both groups with regards to rate of pneumonia (OR 1.26 
[0.75, 2.14]), mortality (OR 0.64 [0.35, 1.18]), discharge destination, length of stay in hospital 
(OR 1.00 [-0.16, 2.16]) and type of diet at 3 months (OR 0.20 [-0.08, 0,48]) (Table 7, 
supplement 4). Patients receiving the study intervention were significantly more frequently 
submitted to instrumental swallowing evaluation. Therefore, this trial could not confirm a 
prior cohort study, which featured a significantly lower incidence of pneumonia in stroke 
patients treated in a hospital using cough reflex testing than in stroke patients treated in 
another hospital that had not embedded this tool in the dysphagia management algorithm 
114. 
Recommendation 3: We suggest a dysphagia assessment in all stroke patients failing a 
dysphagia screening and/or showing other clinical predictors of post-stroke dysphagia, in 
particular a severe facial palsy, severe dysarthria, severe aphasia or an overall severe 
neurological deficit (NIH-SS ≥ 10 points). Dysphagia assessment should be done as soon as 
possible. In addition to the clinical swallow examination, VFSS, or, preferentially, FEES 
should be available. 
Quality of evidence: Low ⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
  
Recommendation 4: We suggest that in acute stroke patients swallowing of tablets should 
routinely be evaluated as part of dysphagia assessment in addition to assessing the 
swallowing of liquid and different food consistencies and quantities.  
Quality of evidence: Low ⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
There were only a small number of studies included in the different meta-analyses pertinent 
to this topic. In addition, the scientific quality of these studies was generally judged to be 
low with risk of bias. However, since the risk of the intervention, i.e. dysphagia assessment, 
is judged to be very low so that its potential benefits outweighs the associated risks, a 
positive recommendation seems warranted 10. Since instrumental assessment is superior to 
the clinical swallowing evaluation, at least one of those techniques should be available with 
FEES being probably more useful and easier to apply than VFSS in the context of acute 
stroke. 
4. Treatment of post-stroke dysphagia 
Mirroring the prognostic importance of PSD there is a significant body of literature dealing 
with a variety of different treatment strategies for this debilitating condition. The 
therapeutic armamentarium has been steadily growing over the last decades and consists of 
dietary and nutritional interventions, behavioural treatment, dedicated oral health care, 
different pharmacological treatment options and peripheral or central neurostimulation 
strategies. In spite of undeniable progress in this notoriously difficult clinical field a Cochrane 
review from 2018 - mainly focusing on the outcomes of death and dependency, did not find 
sufficient evidence to recommend any of these interventions 142. This guideline devotes 12 
PICO questions pertinent to this topic.  
 
4a Dietary interventions 
The use of texture-modified foods and thickened liquids has become a cornerstone of clinical 
practice to address PSD. The principle behind this approach arises from the assumption that 
modifying the properties of normal foods and liquids will make them safer and easier to 
swallow 143. In particular with regards to liquid thickening, several studies 144-146, two 
systematic reviews 143, 147 and one white paper 148 examined the physiological implications of 
this intervention and concordantly showed that with increasing levels of viscosity the risk of 
airway penetration and aspiration is reduced. Recent studies demonstrated the specific 
range of viscosity values providing this effect on safety of swallow in poststroke patients 145, 
149. On the other hand, liquid thickening seems to increase the risk of post-swallow residue 
indicating less effective bolus propulsion 143, 147, 148. Of late, studies suggest that this 
detrimental effect may be ameliorated with gum-based thickeners 145, 149. For decades there 
were no established and universally used terminology and definitions to describe the target 
consistency recommended for dysphagic patients and to guide its preparation 143. Therefore, 
the comparability of studies performed and the validity of conclusions reached in this area 
are principally limited to date. Several countries have developed their own taxonomies or 
classification systems 150. Only recently two different systems have been proposed, the 
“International Dysphagia Diet Standardization Initiative” and the ESSD labelling system 151, 
152.  
The working-group formulated two PICO-questions. 
In patients with post-stroke dysphagia does texture diet modification compared to no 
texture diet modification improve functional outcome and/or survival, reduce aspiration 
risk, reduce length of hospital stay, reduce adverse events and complications, improve 
swallowing status/ ability, have an effect on nutritional status, and have an effect on 
quality of life?  
And: 
In patients with post-stroke dysphagia, does fluid thickening compared to no fluid 
thickening, improve functional outcome and/or survival, reduce aspiration risk, reduce 
length of hospital stay, reduce adverse events and complications, improve swallowing 
status/ ability, have an effect on nutritional status, and have an effect on quality of life?  
Out of 2624 abstracts screened, the meta-analysis included 6 RCTs 153-158 and 3 NRCTs 159-161. 
Since many studies combined interventions with texture modified food and liquid thickening 
and the overall number of RCTs is comparatively low, this meta-analysis does not target each 
intervention separately. Overall, dietary modifications were associated with a trend for a 
decreased risk of pneumonia (RR 0.19 [0.03, 1.40], p=0.1, Table 8, supplement 5). Data on 
mortality and functional outcome were rarely provided. In addition, several studies reported 
a reduced fluid and nutritional intake in patients receiving a modified diet and/or thickened 
liquids 156, 157, 159-161. Although not dedicated to the population of stroke patients, the largest 
RCT in this field should be briefly mentioned here. Robbins and co-workers recruited more 
than 500 patients with dysphagia due to Parkinsonism or dementia and proven aspiration on 
thin liquids. Patients were randomized to thickened liquids or treatment with the chin-down 
posture and normal liquids. There was no difference in the incidence of pneumonia between 
both groups during a three-months follow-up (9.8 vs. 11.6%) 162. 
Recommendations 5: In patients with post-stroke dysphagia, we suggest that texture 
modified diets and/or thickened liquids may be used to reduce the risk of pneumonia. 
Quality of evidence: Low ⊕⊕    
Strength of recommendation: Weak for intervention ↑? 
 
Recommendation 6: In patients with post-stroke dysphagia, we recommend that texture 
modified diets and/or thickened liquids are prescribed only based on an appropriate 
assessment of swallowing.  
Quality of evidence: Low ⊕⊕    
Strength of recommendation: Strong for intervention ↑↑ 
 
Recommendation 7: In stroke patients put on texture modified diet and/or thickened 
liquids we recommend to monitor fluid balance and nutritional intake.  
Quality of evidence: Moderate ⊕⊕⊕   
Strength of recommendation: Strong for intervention ↑↑ 
The number of trials included in the different meta-analyses pertinent to this topic is low 
and the scientific quality of most studies was judged to be low with risk of bias. On the other 
hand, similar risks of the intervention (texture modified diet and liquid thickening) have been 
described across several albeit small trials. To adequately balance benefits and risks of the 
intervention a cautious positive recommendation was supplemented by two strong 
recommendations addressing precautions when implementing the intervention into the 
daily clinical routine.  
 
4.b Behavioural interventions 
Exercises and manoeuvres probably constitute the most widespread treatment approach for 
patients with dysphagia of different aetiologies worldwide. A variety of different 
interventions exist, ranging from direct to indirect, isolated to combined and those 
incorporating swallowing and non-swallowing tasks. Rehabilitation exercises, such as the 
Shaker head lift (targeting patients with impaired opening of the upper esophageal 
sphincter) 163, the Masako manoeuvre (intended to strengthen base of the tongue and 
pharyngeal wall movement) 164 or expiratory muscle strength training (EMST; used for 
strengthening the expiratory and submental muscles) 165 are intended to change and 
improve the swallowing physiology in force, speed or timing and are meant to produce long-
term effects. In contrast to this, compensatory interventions like the Chin-down posture 
(designed to reduce the risk of aspiration in patients with premature spillage) 166 or the 
Mendelsohn manoeuvre (adopted in patients with impaired laryngeal excursion) 167 are used 
for short-term effects on the swallow 168. Finally, acupuncture is an ancient Chinese medical 
technique which has been a common therapy for stroke and many of its different clinical 
sequelae in China 169. 
The working-group formulated one PICO-question. 
In patients with post-stroke dysphagia do behavioural swallowing exercises compared to 
no treatment improve functional outcome and/or survival, reduce aspiration risk, reduce 
length of hospital stay, reduce adverse events and complications, improve swallowing 
status/ ability, have an effect on nutritional status, and have an effect on quality of life?  
Based on the same search as mentioned above (see 4a), 24 RCTs 25, 165, 170-192 and 3 NRCTs 193-
195 were included in this meta-analysis. In addition, 27 RCTs dedicated to acupuncture have 
been analysed separately 196-222. For all different techniques including acupuncture, the 
meta-analysis revealed an improvement of dysphagia severity, which, in a smaller 
proportion of trials, was also reflected by an upgrade of the feeding strategy (Tables 9 and 
10, supplements 6 and 7). 6 RCTs including more than 600 patients showed a significant 
reduction of pneumonia (RR 0.57 [0.43, 0.75]), whereas no effect on functional outcome and 
mortality was observed. For acupuncture no effect on the incidence of pneumonia was 
observed (RR 0.40 [0.08, 1.98]), while quality of life indicators (RR 32 [24.99, 39.01]) were 
improved and removal of a feeding tube was more likely with acupuncture than with sham 
treatment (RR 1.79 [1.27, 2.53]).  
In contrast to most interventions, which were tested in smaller single-centre trials, the study 
of Carnaby and co-workers stood out and had a strong impact on the mentioned findings 171. 
In this multicentre RCT the change of dietary status after usual care (N = 102), standard low-
intensity intervention (N = 102) and standard high-intensity intervention (N = 102) was 
compared. After six months, the percentage of patients returning to a normal diet was 56% 
for usual care, 64% for standard low-intensity and 70% for standard high-intensity 
treatment. In patients who received standard therapy (either low or high intensity) medical 
complications, chest infections and death or institutionalization decreased significantly.  
 
 
Recommendation 8: In patients with post-stroke dysphagia, we suggest behavioural 
swallowing exercises to rehabilitate swallowing function.  
Quality of evidence: Moderate ⊕⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
Recommendation 9: In patients with post-stroke dysphagia, we suggest that behavioural 
interventions should not be limited to one specific manoeuvre or training, but the 
treatment should be tailored to the specific swallowing impairment of the individual 
patient based on a careful assessment of dysphagia.  
Quality of evidence: Moderate ⊕⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
Recommendation 10: In patients with post-stroke dysphagia, we suggest that acupuncture 
may be used to rehabilitate swallowing function.  
Quality of evidence: Moderate ⊕⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
The number of trials included in the different meta-analyses pertinent to this topic is, in part, 
quite high and most results of single trials have a similar trend. The scientific quality of most 
studies was judged to be low with risk of bias. The only exception was a multicentre-trial 
employing a comprehensive behavioural swallowing intervention with different techniques 
in dysphagic stroke patients. 
 
4c Nutritional interventions 
Malnutrition either already present prior to stroke onset or developing thereafter, has been 
identified as key risk factor for increased mortality, worse functional outcome, prolonged 
length of stay in hospital and higher healthcare costs 60. In the clinical context, timing of 
nutritional therapy after stroke and the route of artificial feeding when required are the 
most important topics here.  
The WG has formulated two PICO questions. Because these questions are closely related, an 
overall conclusion is given at the end of this section after the second PICO question has been 
discussed. 
In patients with post-stroke dysphagia does early initiation of oral nutritional therapy 
compared to late initiation of nutritional therapy improve functional outcome and/or 
survival, reduce aspiration risk, reduce length of hospital stay, reduce adverse events and 
complications, improve swallowing status/function, have an effect on nutritional status, 
and have an effect on quality of life? 
Based on the same search as mentioned above (see 4a), five RCTs were included in the 
meta-analysis 223-227. These studies used oral supplementation either in unselected 223 or 
selected stroke patients, in particular those with impaired cognition or with a risk of or 
manifest malnutrition 224-227. Generally, these studies focused on patients free of severe 
dysphagia that would have precluded oral intake. The meta-analysis showed no effect of 
nutritional therapy on the key outcomes, namely mortality (RR 0.88 [0.57, 1.37]), functional 
status (independence) (RR 0.98 [0.91, 1.06]) or pneumonia (RR 1.12 [0.88, 1.42]) (Table 11, 
supplement 8). This result was mainly driven by the first sub-study of the FOOD (feed or 
ordinary diet) trial that randomized more than 4000 patients to normal hospital diet or 
normal hospital diet plus oral nutritional supplements, which failed to show significant 
differences in any of the outcome parameters including among others mortality, functional 
status and in-hospital complications 223, 228. Contrasting with this, the subgroup of smaller 
studies recruiting selected stroke patients showed an impact of the intervention on different 
nutritional parameters (Table 11, supplement 8). 
In patients with post-stroke dysphagia does early enteral or parenteral feeding compared 
to late or restrictive enteral or parenteral feeding improve functional outcome and/or 
survival, reduce aspiration risk, reduce length of hospital stay, reduce adverse events and 
complications, improve swallowing status/ability, have an effect on nutritional status, and 
have an effect on quality of life? 
Based on the same search as mentioned above (see 4a), we included 2 RCTs in the meta-
analysis 229, 230. Available studies employed feeding via a nasogastric tube as intervention. 
This current meta-analysis revealed a trend for a reduction of mortality with early enteral 
nutrition (RR 0.88 [0.76, 1.02], p=0.09) (Table 12, supplement 8); however, tube feeding was 
associated with a trend towards more gastrointestinal bleedings (RR 2.00 [0.98, 4.08], 
p=0.06). This result was mainly driven by the second sub-study of the FOOD (feed or 
ordinary diet) trial that randomized dysphagic stroke patients to either tube feeding or 
delayed feeding started later than 7 days from randomization 228, 229. Allocation to early tube 
feeding was related to a non-significant reduction of mortality by 5.8% (p=0·09) and a higher 
rate of gastrointestinal bleedings, whereas there were no differences with regards to other 
outcomes including functional status, pneumonia and PEG-placement at follow-up. The third 
sub-study of the FOOD trial, which was not part of this meta-analysis due to its different 
focus, compared early feeding via a nasogastric tube with early feeding via a percutaneous 
endoscopic gastrostomy (PEG) tube 228, 229. While there was no difference in mortality 
between both groups, the combined endpoint of death or disability was less frequently seen 
in patients being started on NG tube-feeding. Additionally, there was an increase in pressure 
sores in the PEG-group. 
Recommendation 11: In unselected stroke patients, we suggest to avoid routine use of oral 
nutritional supplementation.  
Quality of evidence: Moderate ⊕⊕⊕   
Strength of recommendation: Weak against intervention ↓? 
 
Recommendation 12: In stroke patients who tolerate an oral diet and present with a risk of 
malnutrition or with manifest malnutrition, we suggest to consider the use of oral 
nutritional supplementation.  
Quality of evidence: Low ⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
Recommendation 13: In patients with post-stroke dysphagia and insufficient oral intake 
we suggest an early enteral nutrition via a nasogastric tube.  
Quality of evidence: Moderate ⊕⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
There were only a small number of high-quality studies available, which mostly did not 
provide an unequivocal answer to the respective research question. Most studies recruited a 
limited number of patients and their scientific quality was generally judged to be low with 
risk of bias. However, since the risks of the interventions, i.e. oral nutritional 
supplementation and tube feeding, are judged to be low so that its potential benefits 
outweigh the associated risks, a positive recommendation seems warranted 10. 
 
4d Interventions to improve oral health 
In particular in stroke patients and geriatric patient cohorts poor oral health in combination 
with dysphagia has been identified as a dominant risk factor for aspiration pneumonia 231-234. 
In addition to periodontitis, gingivitis, plaque formation and caries, respiratory pathogens 
such as Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, 
Klebsiella oxytoca, Pseudomonas aeruginosa and Escherichia coli have frequently been 
detected in the oral cavity of these patients 234, 235. The aspiration of bacterial contaminated 
saliva is therefore considered to be the main pathogenic mechanism of pulmonary infections 
in severely dysphagic stroke patients fed via a gastric tube 128, 236. In order to avoid 
aspiration-related respiratory infections, interventions to improve oral health are considered 
as therapeutic option in this patient cohort.  
The working-group formulated one PICO-question. 
In patients with post-stroke dysphagia does specific oral health care compared to standard 
care improve functional outcome and/or survival, reduce aspiration risk, reduce length of 
hospital stay, reduce adverse events and complications, improve swallowing status/ 
ability, have an effect on nutritional status, and have an effect on quality of life? 
Based on the same search as mentioned above (see 4a), 4 RCTs 237-240 and 4 NRCTs 84, 241-243 
were included in the meta-analysis. The interventions to improve oral health mostly 
consisted of different oral care protocols including mechanical cleaning and mouth rinsing, in 
part with additional antimicrobial agents added 84, 237. One study specifically focused on the 
eradication of oral pathogens using a mixture of different non-absorbable antibiotics and 
antimycotics (“selective oral decontamination”) 238. Most trials used different oral health 
scales and pneumonia as key outcome parameters. Our meta-analysis revealed that RCTs 
dedicated to oral health interventions were associated with a trend towards a reduction of 
pneumonia (RR 0.14 [0.02, 1.11], p=0.06), a significant reduction in tube feeding (RR 0.43 
[0.28, 0.65]) and a significant improvement of oral health conditions (SMD -1.27 [-2.26, -
0.28]) (Table 13, supplement 9). Other endpoints pertinent to this meta-analysis, in 
particular mortality and functional outcome were rarely evaluated and not systematically 
influenced by this intervention across in RCTs. 
Recommendation 14: In stroke patients we suggest to implement oral health care 
interventions to reduce the risk of pneumonia.  
Quality of evidence: Low ⊕⊕   
Strength of recommendation: Weak for intervention ↑?  
 
There were only a small number of studies available and the scientific quality of these 
studies was generally judged to be low with risk of bias. However, since the risk of the 
intervention, i.e. oral health care, is judged to be very low so that its potential benefits 
outweighs the associated risks, a positive recommendation seems warranted 10. 
 
4e Pharmacological treatment 
Pharmacological treatment options of PSD involve the use of drugs that stimulate the neural 
pathways of deglutition either on the peripheral sensory level or at different levels of the 
central nervous system 132. Classes of pharmacological agents that have been evaluated for 
their potential to improve disordered swallowing are TRPV1 (transient receptor potential 
cation channel subfamily V member 1) agonists, angiotensin-converting-enzyme-inhibitors 
and dopaminergic agents. TRPV1, TRPA1 (transient receptor potential cation channel, 
subfamily A, member 1), and TRPM8 (transient receptor potential cation channel subfamily 
M, member 8) agonists, in particular capsaicinoids (TRPV1 agonist), piperine (dual TRPV1 and 
TRPM8 agonist), and menthol (TRPM8 agonist), stimulate the respective receptors expressed 
at free nerve endings of the superior laryngeal nerve and the glossopharyngeal nerve 244 and 
increase salivary substance P levels, a neurotransmitter which is released from sensory nerve 
terminals in the pharynx and which is intimately involved in the control of deglutition 132. 
ACE inhibitors are widely used antihypertensive drugs that can cause a dry cough as a side-
effect. One of the mechanisms for this side-effect is the decreased degradation of substance 
P, which implies that any effect of this drug group on the act of deglutition may be due to a 
similar mechanism as has been suggested for TRPV1 agonists. With regards to dopaminergic 
agents the mechanism of action with regards to a potential effect on dysphagia has not been 
elucidated. However, loss of dopaminergic neurons in the central nervous system because of 
stroke or neurodegenerative diseases is known to contribute to dysphagia and is associated 
with a decreased swallow reflex 245.  
On the other hand, intravenous application of different broad-spectrum antibiotics has been 
used to prevent infectious complications, in particular aspiration pneumonia 246. Finally, 
prokinetic drugs have been used in tube-fed dysphagic stroke patients to prevent reflux and 
concomitant aspiration 60. 
The working group formulated one PICO question. 
1. In patients with post-stroke dysphagia, does pharmacological treatment compared to no 
treatment improve functional outcome and/or survival, reduce aspiration risk, reduce 
length of hospital stay, reduce adverse events and complications, improve swallowing 
status/ ability, have an effect on nutritional status, and have an effect on quality of life? 
Based on the same search as mentioned above (see 4a), we included 24 RCT 121, 247-270 and 9 
NRCT in the meta-analysis  271-279 (Table 14, supplement 10). For all three types of 
pharmacological agents targeting the swallowing network, the meta-analysis revealed 
significant effects on swallowing physiology, in particular a shortening of the pharyngeal 
swallow response, that likely contributed to an improved swallowing safety. However, these 
promising findings have rarely been supported by studies looking for clinical endpoints. 
Apart from one smaller trial using a combination of ACE-inhibitors and Amantadine in a 
cohort of geriatric stroke victims with pneumonia our meta-analysis did not show an effect 
of either of these drugs on mortality. With regards to the endpoint pneumonia, results have 
been somewhat more promising but remain ambiguous. While in nonrandomized trials a 
significant reduction of this complication has been observed for ACE inhibitors (RR 0.60 
[0.51, 0.70]) and TRPV1 agonists (RR 0.31 [0.15, 0.66]), this was not confirmed by the meta-
analysis of RCTs. With regards to dopaminergic drugs, Nakagawa and co-workers showed in 
a comparatively large RCT (n=163) that treatment with amantadine compared to placebo 
significantly decreased the rate of pneumonia in patients post stroke over the study period 
of three years (RR 0.22 [0.09, 0.55]) 259.  
Preventive antimicrobial treatment has been evaluated in 7 RCTs recruiting 4301 patients. 
According to our meta-analysis there is no effect on the key endpoints mortality, functional 
outcome and pneumonia (Table 14, supplement 10).  
The prokinetic drug metoclopramide has been evaluated in a phase II RCT in tube-fed stroke 
patients. Treatment with metoclopramide was associated with a significant reduction of 
pneumonia (RR 0.31 [0.17, 0.57]) 265. 
 
Recommendation 15: We recommend that due to the limited evidence available with 
regards to clinical endpoints, pharmacological treatment of post-stroke dysphagia should 
be preferably used within clinical trial settings.  
Quality of evidence: low ⊕⊕  
Strength of recommendation: Strong for intervention ↑↑ 
 
Recommendation 16: We recommend that preventive antimicrobial treatment is not used 
in stroke patients.  
Quality of evidence: High ⊕⊕⊕⊕   
Strength of recommendation: Strong against intervention ↓↓ 
 
Recommendation 17: In stroke patients with post-stroke dysphagia and an impaired 
swallow response, we suggest to consider TRPV1 agonists and dopaminergic agents to 
improve swallowing safety. Quality of evidence: Low ⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
 
Recommendation 18: In stroke patients fed via a nasogastric tube, we suggest to use 
metoclopramide to promote gastric emptying and reduce the risk of esophago-pharyngeal 
regurgitation with subsequent aspiration.  
Quality of evidence: Low ⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
There were only a limited number of studies included in the different meta-analyses 
pertinent to this topic. In addition, the scientific quality of these studies was generally 
judged to be low with risk of bias. Since most results point to an effect of treatment a 
cautious positive recommendation seems warranted that includes the suggestion to 
preferably use the mentioned pharmacological options within trials.  
 
4f Neurostimulation treatment 
Neurostimulation techniques include transcutaneous electrical stimulation (TES), repetitive 
transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS) and 
pharyngeal electrical stimulation (PES). TES is used to activate sensory nerves (SES = sensory 
transcutaneous electrical stimulation) or muscles (NMES = neuromuscular electrical 
stimulation) involved in swallowing function through stimulation of axonal motor nerve 
endings and muscle fibres. Its mechanism of action is thought to include promoting central 
nervous system recovery and accelerating the development of muscle strength. Non-
invasive brain stimulation is based on the principle of neuroplasticity, best defined as 
changes in neuronal pathways to increase neural functioning via synaptogenesis, 
reorganization, and network strengthening and suppression. The two most commonly used 
techniques to directly target cortical areas are tDCS and rTMS, whereas PES applies 
stimulation to pharyngeal structures, indirectly targeting the pharyngeal motor and sensory 
cortices and related brain areas and possibly also working on the peripheral sensory afferent 
system 60, 280. All these treatments are usually used as adjunct to a given standard of care. 
Therefore, in most randomized trials pertinent to this topic a given neurostimulation method 
or the respective sham stimulation has been added to a specific behavioural swallowing 
intervention. In addition, in some studies, a three-arm design was adopted, where either 
two different interventions were compared against a sham condition or a combination of 
treatments were studied against each single intervention. To account for these differences in 
trial design, the WG formulated two PICO questions: 
1. In patients with post-stroke dysphagia, do neurostimulation techniques compared to no 
treatment, improve functional outcome and/or survival, reduce aspiration risk, reduce 
length of hospital stay, reduce adverse events and complications, improve swallowing 
status/ ability, have an effect on nutritional status, and have an effect on quality of life?  
2. In patients with post-stroke dysphagia, do neurostimulation techniques compared to 
behavioural treatments improve functional outcome and/or survival, reduce aspiration 
risk, reduce length of hospital stay, reduce adverse events and complications, improve 
swallowing status/ ability, have an effect on nutritional status, and have an effect on 
quality of life? 
Based on the same search as mentioned above (see 4a), 35 RCTs 173, 281-314  and 6 NRCT 315-320 
were included in the meta-analysis (Table 15, supplement 11). All trials reported data on 
swallowing performance using a variety of different scales and nearly all trials used a local 
standard of care, mostly consisting of different behavioural swallow interventions as control. 
Most studies have been dedicated to different versions of TES, followed by rTMS, tDCS and 
PES. For most stimulation methods meta-analyses of RCTs revealed a significant 
improvement of swallowing function compared to sham stimulation (SMD 1.51 [0.60, 2.42] 
for rTMS, SMD 0.90 [0.60, 1.19] for TES, and SMD 0.75 [0.38, 1.12] for tDCS), for PES the 
treatment effect just failed to be significant (SMD 0.77 [-0.06, 1.60], p=0.07). Clinically more 
relevant endpoints, however, have been studied and achieved much rarer. Neurostimulation 
was associated with a modest impact on functional outcome. Two PES trials including 177 
patients showed a significant impact of the intervention on the mRS (MD -0.33 [-0.63, -0.02]) 
and results from 4 rTMS trials including 86 patients showed an effect of the stimulation on 
the BI (MD 31.57 [27.75, 35.39]). No significant effect of neurostimulation on mortality, 
pneumonia and length of stay could be determined, whereas results on quality-of-life 
indicators, although less frequently studied, have been promising in part, in particular for 
TES. Finally, two RCTs targeted the subgroup of tracheotomized stroke patients with meta-
analysis showing that PES was significantly associated with removal of the tracheal cannula 
(RR 4.64 [2.00, 10.79]). All these mentioned results of RCTs have generally been supported 
by non-randomized studies. 
 
Recommendation 19: In patients with post-stroke dysphagia, we recommend that 
treatment with neurostimulation techniques should preferably be conducted within a 
clinical trial setting.  
Quality of evidence: low ⊕⊕    




Recommendation 20: In patients with post-stroke dysphagia, we suggest treatment with 
rTMS, TES, tDCS and PES as adjunct to conventional dysphagia treatments to improve 
swallowing function.  
Quality of evidence: Moderate ⊕⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
Recommendation 21: In tracheotomized stroke patients with severe dysphagia, we suggest 
treatment with pharyngeal electrical stimulation to accelerate decannulation.  
Quality of evidence: High ⊕⊕⊕⊕   
Strength of recommendation: Weak for intervention ↑? 
 
The number of trials included into the different meta-analyses pertinent to this topic is, in 
part, quite high and most results of single trials have a similar trend which in most cases is 
also in line with results from non-randomized trials. In addition, reports of adverse events 
were very low, making these treatments safe to apply. The scientific quality of most studies 




This ESO and ESSD Guideline on PSD provides an in-depth guide for all members of the 
multidisciplinary team. This is one of the most rigorous meta-analysis in the field, adding a 
considerable body of evidence to previous publications and guidance with regards to 
screening, assessment, management, and factors that will affect PSD health outcomes (Table 
16 provides a summary of recommendations). In addition, in two cases where the available 
evidence was very limited and the topic in question of considerable clinical importance, 
recommendations of previously published guidelines were adopted. 
It was clearly demonstrated that the presence of PSD impacts on nearly all the different 
levels of outcomes, ranging from mortality rate to quality-of-life. Acute as well as subacute 
PSD patients presented higher mortality rates, peaking at 1-month and 3 months post-stroke 
and endured longer hospital stay. Patients with PSD present a 7-fold higher incidence of 
pneumonia; the latter being well-documented to be responsible for up to one-third of post-
stroke deaths 321.  Pneumonia rates in PSD was one of the most investigated endpoints 
within this meta-analysis (total of 28 studies and 108056 patients). Approximately half that 
number appeared in investigations on the effects of formal screening on pneumonia rates. 
Even though the evidence quality was low, screening for PSD was related to reduced risk of 
pneumonia (OR 0.55 [0.36, 0.83]) and a trend for reduced mortality in acute stroke patients 
screened for dysphagia.  
Of interest, in the clinical setting in patients who fail the swallow screen, more detailed 
assessment of dysphagia is performed. We found that there was a small number of studies, 
judged of low quality with risk-of-bias, for the impact of routinely formal instrumental 
assessment on outcomes. Nevertheless, a positive recommendation was assigned here, 
because detailed instrumental studies benefit the decision-making process concerning route 
of feeding and the optimal therapeutic approach, thus outweighing any associated risks. 
Evidence shows that specific instrumental assessments, such as FEES performed at the 
bedside 322 can reduce pneumonia rates and increase functional outcomes 109, 131, 135, 323.  
With regards to the management of PSD, evidence concerning the use of thickened liquids 
and modified diets to reduce pneumonia is weak and remains controversial, in keeping with 
others 324. Although there is evidence showing that by increasing levels of viscosity the risk of 
airway penetration and aspiration is reduced 143, 147, 148, and recent studies with gum-based 
thickeners showed the specific range of viscosity values providing this therapeutic effect on 
safety of swallow 145, 149, long term studies showing the clinical impact of fluid thickening in 
poststroke patients are clearly required. The heterogeneity in the studies evaluated here 
showed that there is probably a need for individualized assessment prior to prescription of 
thickened fluids and modified diet, which again should be monitored. Monitoring is 
important since there are several studies 155, 156, 159, 160 that showed that modification of food 
may result in nutritional compromise.  
There is currently moderate level of evidence for the effects of behavioural therapy, 
including swallowing and non-swallowing tasks, on pneumonia rates and swallowing specific 
scores. Other strategies included oral health interventions, where a small number of low-
quality studies was included. The landscape was similar for the pharmacological therapy, 
where ACE inhibitors showed a low likelihood for an effect on pneumonia rates following 
combination of RCTs and non-RCTs [12 studies – 10611 patients: OR 0.60 (0.51, 0.70)]. Yet, 
the prescription of specific medication should be evaluated in detail on stroke patients and 
the formulation should be decided upon their swallowing ability. Interestingly, the largest 
number of included studies was observed with neurostimulation treatment for PSD. Here, 
the nature of the treatments is shown to be very diverse including muscular stimulation as 
well as peripheral, central, or combined approaches. The heterogeneity was substantial, 
given that the outcome measures in the studies were diverse. Some techniques showed 
greater likelihood to impact on overall dysphagia and QOL scales, while others on overall 
functional scores (for example Barthel index) and decannulation. Here the recommendation 
is for the use of the techniques within a research context, in particular controlled trials, until 
further evidence surfaces. 
Concerning early oral nutritional therapy (and supplementation) in PSD, even with the 
inclusion of 5 RCTs in this meta-analysis, we concluded that there is no evidence to routinely 
employ this intervention. However, nutritional supplementation could be considered for 
patients with manifest malnutrition or risk of malnutrition who can tolerate oral diet. The 
quality of evidence was somewhat stronger for the use of early enteral nutrition in severe 
PSD, but still there was no specific effect on pneumonia rates or other outcome measures. 
It was noteworthy that completion of this meta-analysis was particularly difficult given the 
high heterogeneity and different methodologies in the studies included. Also, there were 
only a few multicentre trials and few RCTs, indicating that further research is warranted. 
Inability to reach higher level of evidence in certain PICOs was partially due to the 
methodological insufficiencies. Moreover, there were different outcome measures utilised in 
the studies to either capture data or record functional change in PSD (imaging 
measurements like kinematics and swallowing durations versus functional scales, i.e. FOIS). 
There are also definition differences, i.e. for pneumonia and differences amongst the 
screening and assessment tools used. The large number of different screening tools 
published with varying levels of sensitivities and specificities could potentially impact on the 
level of evidence. Nonetheless, this extensive meta-analysis was completed with rigor and 
when there was limited evidence base, recommendation was made based on best available 
empirical support.  
Current barriers for the application of the clinical guidelines in stroke units need to be taken 
into consideration. Of importance is the appropriate training of specified members of the 
multidisciplinary team on dysphagia screening and assessment procedures and the means to 
renew and update their knowledge at specified time points. Training is needed for the 
inclusion of the instrumental assessments (FEES, VFSS) in the clinics as well as business case 
for their availability. Treatment and management procedures could face similar barriers to 
the above, such as training and availability, in particular in the means of availability on a 
daily basis for stroke patients. 
Finally, future research in this field is warranted and consensus on the outcome and 
endpoints of the research studies is needed to allow for better clinical recommendations. 
Better designed studies will surface if the inclusion criteria in the trials are well-
characterised, especially the time-window of the recovery phase for PSD, the control groups, 
and the definition of the usual and standard care. Regarding the outcome measures, 
functional as well as dysphagia specific measures should be included and consensus should 
be sought for the comparability of different methodologies and tools where required.   
  
Table 1. Grading of outcomes 
Scale OUTCOME Same level 
Outcomes 
DEFINITIONS 
9 Mortality  MRS Critical for making a 
decision 






7 Aspiration risk  Feeding strategy  
6 Swallowing function  




important, but not critical 
for 
making a decision (included 
in 
evidence profile) 4 Quality of life  
3 laboratory parameters linked 
to malnutrition 
 
2 Feeding tube failures and 
adverse events 
Withdrawal of tube 
feeding, Costs 
of limited importance for 
making a 
decision (not included in 
evidence 
profile) 
1   
  
Table 2. Effect of dysphagia compared to no dysphagia on key outcomes 
 
Outcome Incidence (%)/ MeanSD Studies n (N) OR [95% CI]/ 
MD [95% CI] 
I2 P value 
Dysphagia No 
dysphagia 




17, 30, 37, 41, 48, 





17.50] 96% < 0.00001 
• Mortality, 3 
months 16% 1% 
15, 17, 19, 32, 49, 
51 5(13546) 
9.02 [4.50, 
18.09] 73% < 0.00001 
• Mortality, 1 
year 42% 32% 
20, 37, 46, 49-51, 
54 7(10737) 
8.82 [3.56, 
21.85] 98% < 0.00001 
Pneumonia 
22% 3% 
7, 15-18, 21, 22, 
24-29, 34, 35, 37-




9.24] 94% < 0.00001 
Tube feeding        
• Nasogastric 




361.14] 35% < 0.00001 
• Percutaneo
us feeding 
tube 9% 0.1% 
17, 26, 37, 47 
4(8446) 
71.60 [34.38, 
149.11] 0% < 0.00001 
mRS        





0.35] 83% < 0.00001 
• mRS ≥2 
76% 55% 
15, 17, 37, 48 
3(17858) 
2.34 [1.24, 
4.40] 98% 0.08 





5.72] NA < 0.00001 
LOS        
• LOS overall, 
days 
12.19.7 8.46.2 
7, 15, 17, 20, 23, 
26, 30, 37, 40, 46-




5.91] 99% < 0.00001 
• LOS stroke 




2.28] NAs < 0.00001 
Discharge 
status   
 
    
• Discharged 
home 17% 67% 
17, 28, 37, 40, 47, 








Palliative 49% 26% 





5.21] 81% < 0.00001 
• Discharged 
to long term 





5.32] 100% 0.19 
• Readmission




0.93] NA 0.02 
CI: Confidence intervals; FOIS: Functional oral intake scale; I2: Heterogeneity; LOS, Length of 
stay in hospital; MD: Mean difference; n: Number of studies; N: Number of patients; NIHSS: 




Table 3. Effect of screening compared to no screening on key outcomes 
 
Outcome Incidence (%)/ 
MeanSD 
Studies n (N) OR [95% CI]/ 
MD [95% CI] 
I2 P value 
Screening No 
Screening 
Mortality        
• Mortality, 
hospital 2% 4% 
40, 71-73 
4(20806) 0.67 [0.45, 1.02] 57% 0.06 
• Mortality, 1 
month 10% 31% 
74, 76, 77 
3(66162) 0.57 [0.12, 2.80] 99% 0.49 
Pneumonia 
7% 10% 
15, 40, 47, 71-
74, 76-80 11(536650) 0.55 [0.36, 0.83] 99% 0.004 
Nasogastric tube, 
insertion 44% 53% 
47, 71, 73 
3(459) 0.86 [0.51, 1.45] 0% 0.58 
Endotracheal tube 
insertion 7% 9% 
71, 73 
2(260) 0.66 [0.27, 1.63] 0% 0.37 
LOS, days 7.26.4 6.25.3 40, 47, 71-73 5(21005) 0.02 [-2.22, 2.26] 99% 0.99 
Discharge        
• Discharged 
home 29% 33% 
40, 77 
2(20348) 0.84 [0.79, 0.90] 0% 
< 
0.00001 
• Discharged to 
Institution 20% 19% 
77 
1(2334) 1.08 [0.86, 1.35] NA 0.53 
• Skilled nursing 
facility 14% 11% 
77 
1(2334) 1.27 [0.97, 1.66] NA 0.09 
• Hospice 2% 3% 77 1(2334) 0.78 [0.43, 1.39] NA 0.39 
• Other hospitals 6% 5% 77 1(2334) 1.28 [0.86, 1.92] NA 0.23 
CI: Confidence intervals; I2: Heterogeneity; LOS, Length of stay in hospital; MD: Mean 
difference; n: Number of studies; N: Number of patients; p: Statistical significance value; OR: 
Odds Ratio; SD: Standard deviation; UTI: Urinary tract infection 
 
  
Table 4. Effect of early screening compared to late screening on key outcomes 
 
Outcome Incidence (%)/ 
MeanSD 
Studies n (N) OR [95% CI]/ 
MD [95% CI] 





Mortality        
• Overall 15% 23% 74, 81-84 7(144307) 0.62 [0.43, 0.91] 99% 0.01 
• Mortality, 
hospital/ 7 
days 5% 6% 
81-83 
4(55969) 0.74 [0.61, 0.89] 75% 0.002 
• Mortality, 1 
month 11% 16% 
74, 83, 84 
5(140614) 0.66 [0.42, 1.02] 99% 0.06 
• Mortality, 1 
year 26% 27% 
83 




82, 84-89 10(96367) 0.45 [0.35, 0.58] 83%  < 0.00001 
LOS, days 23.89.5 27.69.2 81-84, 90 6(56085) -2.27 [-3.12, -1.43] 92% < 0.00001 
Barthel Index 
Score, discharge 1743 1228 
84 
1(116) 5.00 [-8.21, 18.21] NA 0.46 
Discharge        
• Discharged 
home 57% 53% 
83 
2(52276) 1.16 [1.08, 1.26] 79% < 0.0001 
• Readmission 2% 6% 85 1(138) 0.35 [0.06, 2.19] NA 0.69 
mRS        
• mRS, 4-5 28% 39% 81 1(3309) 0.59 [0.50, 0.71] NA 0.00001 
CI: Confidence intervals; I2: Heterogeneity; LOS, Length of stay in hospital; MD: Mean 
difference; n: Number of studies; N: Number of patients; p: Statistical significance value; 
PEG: Percutaneous endoscopic gastrostomy; OR: Odds Ratio; SD: Standard deviation; LOS: 
Length of stay 
 
  
Table 5. Effect of clinical bedside assessment compared to instrumental assessment on key outcomes 
Outcome Incidence (%) Studies n (N) OR [95% CI] / 
MD [95% CI] 






Mortality 10.5% 7.3% 135 1(440) 1.49 [0.76, 2.90] NA 0.24 
Pneumonia 12.3% 6.4% 135 1(440) 2.06 [1.05, 4.04] NA 0.04 
Discharge, 
home 43.6% 46.4% 
135 
1(440) 0.90 [0.62, 1.30] NA 0.57 
Discharge, on 
standard diet 51.1% 65.6% 
135 
1(378) 0.47 [0.31, 0.71] NA 0.004 
LOS, days 17.3±15.2 23.7±20.2 135 1(440) -6.33 [-9.67, -2.99] NA 0.0002 
CI: Confidence intervals; I2: Heterogeneity; LOS: Length of stay in hospital; n: Number of studies; N: 
Number of patients; NA: Not applicable; p: Statistical significance value; OR: Odds Ratio 
Table 6. Effect of instrumental assessment with FEES compared to instrumental assessment with 
VFSS on key outcomes. 
Outcome Incidence (%) Studies n (N) OR [95% CI]/ 
MD [95% CI] 
I2 P value 
VFSS FEES 
Pneumonia 29.2% 4.8% 140 1(45) 8.24 [0.92, 73.79] NA 0.06 
PEG 2.6% 23.8% 140 1(99) 0.08 [0.01, 0.47] NA 0.005 
CI: Confidence intervals; FEES: fiberoptic endoscopic evaluation of swallowing; I2: Heterogeneity; n: 
Number of studies; N: Number of patients; NA: Not applicable; p: Statistical significance value; PEG: 
Percutaneous endoscopic gastrostomy; OR: Odds Ratio 
 
Table 7. Effect of complementary and standard assessment in patients with acute or subacute stroke 
Outcome Incidence (%)/ MeanSD Studies n (N) OR [95% CI]/ 







Mortality  13.5% 19.6% 141 1(311) 0.64 [0.35, 1.18] NA 0.15 
Pneumonia 25.7% 21.5% 141 1(311) 1.26 [0.75, 2.14] NA 0.38 
Independence         
• At home 48.6% 44.8% 141 1(311) 1.17 [0.75, 1.83] NA 0.50 
• At residential care 43.2% 45.4% 141 1(311) 0.92 [0.59, 1.43] NA 0.70 
• At public hospital 8.1% 9.8% 141 1(311) 0.81 [0.37, 1.78] NA 0.60 
Length of stay 75.2 65.2 141 1(311) 1.00 [-0.16, 2.16] NA 0.09 
FOIS 6.21.2 61.3 141 1(311) 0.20 [-0.08, 0.48] NA 0.16 
CI: Confidence intervals; I2: Heterogeneity; MD: Mean difference; n: Number of studies; N: Number 
of patients; NA: Not applicable; p: Statistical significance value; OR: Odds Ratio; SD: Standard 
deviation; FOIS: Functional oral intake scale 
  
Table 8. Effect of consistency modification on key outcomes 
Outcome Incidence % Studies n (N) RR [95% CI]/ 
MD [95% CI] 




Pneumonia        
• RCT 0.0% 20.0% 154, 156, 
158 
4(100) 0.19 [0.03, 1.40] 0% 0.1 
Penetration        
• RCT 0.0% 13.1% 153 1(122) 0.06 [0.00, 1.00] NA 0.05 
Aspiration        
• RCT 21.3% 45.7% 153-155 3(188) 0.51 [0.14, 1.77] 90%  0.29 
LOS in hospital 
(days) 
       
• RCT 24±9 34±12 158 1(64) -9.58 [-15.41, -
3.76] 
19%  0.001 
Fluid intake (ml)        
• Overall 1179±235 1612±455 156, 157, 
160 
3(77) -133.22 [-541.90, 
275.46] 
94%  0.52 
• RCT 745±164 649±172 156, 157 2(38) 140.48 [-41.56, 
322.51] 
68% 0.13 






Kcal/kg/day   
 






1.29] NA 0.18 
• Protein 
intake, 
g/kg/day   
 






0.04] NA 0.02 
CI: Confidence intervals; I2: Heterogeneity; MD: Mean difference; n: Number of studies; N: Number 
of patients; p: Statistical significance value; RR: Risk Ratio; SD: Standard deviation 
  
Table 9. Effect of behavioural therapy on key outcomes and dysphagia scores 
 
Outcome Mean±SD/ Incidence (%) Studies n (N) RR [95% CI]/ 
MD [95% CI] 
I2  P value 
Behaviour Control 
Mortality        
• RCT 15.1% 10.7% 25, 170, 171 3(505) 1.47 [0.32, 
6.78] 
71% 0.62 
mRS, RCT        
• mRS ≥3 50.5% 48.0% 171 1(306) 1.05 [0.82, 
1.34] 
NA 0.69 
Pneumonia        
• Overall 18.4% 24.5% 25, 170, 171, 
173, 183, 184 
6(677) 0.57 [0.43, 
0.75] 
0% < 0.0001 
• EMST, RCT 11.6% 19.0% 173, 183, 184 3(196) 0.58 [0.24, 
1.41] 
22%  0.23 
• Swallowing 
exercises, RCT 
21.3% 26.6% 25, 170, 171 3(481) 0.56 [0.41, 
0.76] 
0% 0.0002 
LOS        
• Swallowing 
exercise, RCT 
19.2±1.2 21.4±12.4 171 1(306) -2.20 [-4.61, 
0.21] 
NA 0.07 
Tube feeding       






       




18(510) 1.18 [0.78, 
1.57] 
70% <0.00001 




16(440) 0.97 [0.64, 
1.30] 
68% <0.00001 
• EMST, RCT 1.4±1.3 0.7±1.4 165, 172, 173, 
185 
4(108) 0.99 [0.51, 
1.47] 




7.6±4.2 5.1±4.1 101, 175-177, 
181, 186-190, 
192-194 





6.1±3.4 3.9±3.3 101, 175-177, 
181, 186-190, 
192 









CI: Confidence intervals; I2, p: Heterogeneity; n: Number of studies; N: Number of patients; NA: Not 
applicable; NRCT: Non-randomized controlled trial; p: Statistical significance value; SD: Standard 
Deviation; MD: Mean Difference; RCT: Randomized controlled trial; RR: Risk Ratio; EMST: Expiratory 
muscle strength training 
  
Table 10. Effect of acupuncture on key outcomes 
 
Outcome Mean±SD/ Incidence 
(%) 
Studies n (N) RR [95% CI]/ 
(S)MD [95% CI] 




20.0% 39.6% 196 198-208, 
210-214, 216, 
218-222 




       
• Improv
ement 




1.50.7 2.10.9 197, 199, 208, 
212, 217 
5(443) -0.63 [-1.12, -0.14] 84% 0.01 
Pneumoni
a 
3.3% 8.3% 200 1(120) 0.40 [0.08, 1.98] NA 0.26 





89.5% 50.0% 198 1(74) 1.79 [1.27, 2.53] NA 0.0009 





       
• Pain 1.7% 0.0% 217 1(120) 3.00 [0.12, 72.20] NA 0.5 
• Hemat
oma 
3.3% 0.0% 217 1(120) 5.00 [0.25, 102.00] NA 0.3 
• Discom
fort 
11.7% 8.3% 217 1(120) 1.40 [0.47, 4.17] NA 0.55 
*: Standard Mean Difference; CI: Confidence intervals; I2: Heterogeneity; n: Number of studies; N: 
Number of patients; NA: Not applicable; p: Statistical significance value; SD: Standard Deviation; MD: 




Table 11. Effect of early compared to late initiation of oral nutritional therapy on key outcomes 
Outcome Incidence (%) Studies n (N) RR [95% CI]/ 
MD [95% CI] 





Mortality        
• RCT 11.7% 12.6% 223-226 4(4337) 0.88 [0.57, 1.37] 26% 0.57 
Pneumonia        
• RCT 6.4% 5.8% 223 1(4023) 1.12 [0.88, 1.42] NA 0.38 
MRS, RCT        
mRS, 0, 1 23.4% 23.5% 223 1(4023) 1.00 [0.89, 1.11] NA 0.94 
mRS, 0-2 40.4% 41.1% 223 1(4023) 0.98 [0.91, 1.06] NA 0.68 
Recurrent stroke        
• RCT 2.5% 2.1% 223 1(4023) 1.16 [0.77, 1.73] NA 0.48 
Infections        
• RCT 8.5% 10.0% 223 1(4023) 0.86 [0.71, 1.04] NA 0.12 
Pressure sores        
• RCT 0.7% 1.3% 223 1(4023) 0.57 [0.31, 1.08] NA 0.09 
GIT haemorrhage        
• RCT 1.4% 0.9% 223 1(4023) 1.55 [0.86, 2.79] NA 0.15 
Length of stay, days        
• RCT 31.146.5 31.443.2 223-226 4(4289) 0.93 [-1.05, 2.91] 0% 0.36 
Weight, change, kg        
• RCT 0.01.7 -1.12.1 225-227 4(315) 1.03 [0.17, 1.89] 91% 0.02 
Energy, kJ/kg        
• RCT 61.620.8 49.715.0 225, 227 5(264) 8.25 [1.97, 
14.53] 
81% 0.01 
Protein intake, g/kg        
• RCT 0.90.3 0.70.3 225, 227 5(264) 0.21 [0.01, 0.41] 88% 0.04 
 
CI: Confidence intervals; I2,,p: Heterogeneity; n: Number of studies; N: Number of patients; MD: 
Mean differecne; NA: Not applicable; p: Statistical significance value; RR: Risk Ratio; GIT: 
Gastrointestinal tract; RR: Risk ratio 
Table 12. Effect of early compared to late or restrictive enteral or parenteral nutrition therapy on key 
outcomes 
Outcome Incidence (%) Studies n (N) RR [95% CI]/ 









Mortality        
• RCT 42.4% 48.1% 229 1(859) 0.88 [0.76, 1.02] NA 0.09 
Pneumonia        
• RCT 28.4% 29.5% 229, 230 2(1005) 0.97 [0.80, 1.17] 0% 0.75 
MRS (RCT)        
• mRS, 0, 1 5.7% 7.0% 229, 230 2(981) 0.84 [0.36, 1.94] 65% 0.68 
• mRS, 0-2 9.3% 10.2% 229 1(859) 0.91 [0.61, 1.37] NA 0.65 
Recurrent stroke        
• RCT 3.5% 5.3% 229 1(859) 0.65 [0.35, 1.24] NA 0.19 
Infections        
• RCT 23.8% 27.3% 229, 230 2(1005) 0.80 [0.55, 1.18] 65% 0.27 
Pressure sores        
• RCT 2.8% 2.3% 229 1(859) 1.20 [0.53, 2.75] NA 0.66 
Malnutrition        
• RCT 27.1% 48.3% 230 1(128) 0.56 [0.35, 0.90] NA 0.02 
GIT haemorrhage        
• RCT 5.1% 2.6% 229 1(859) 2.00 [0.98, 4.08] NA 0.06 
Length of stay, days        
• RCT 
4558 4450 
229 1(859) 1.00 [-6.24, 
8.24] NA 0.79 
BI        
• RCT 
46.78.8 44.49.3 
230 1(146) 2.30 [-0.64, 
5.24] NA 0.13 
Living at home        
• RCT 35.7% 31.6% 229 1(859) 1.13 [0.93, 1.36] NA 0.21 
Living in Rehabilitation/ 
institution   
 
    
• RCT 21.9% 20.0% 229 1(859) 1.10 [0.84, 1.42] NA 0.49 
Nasogastric tube        
• RCT 7.0% 5.3% 229 1(859) 1.31 [0.77, 2.21] NA 0.32 
PEG        
• RCT 3.3% 2.3% 229 1(859) 1.40 [0.63, 3.12] NA 0.41 
 
CI: Confidence intervals; I2,,p: Heterogeneity; n: Number of studies; N: Number of patients; MD: 
Mean difference; NA: Not applicable; p: Statistical significance value; RR: Risk Ratio; BI: Barthel Index 
 
 
Table 13. Effects of oral health interventions on key outcomes 
Outcome Incidence % Studies n (N) RR [95% CI]/ 
(S)MD [95% CI] 




Mortality        
• Overall 17.4% 29.8% 84, 238 3(349) 0.66 [0.45, 0.96] 0%  0.03 
• RCT 8.7% 14.0% 238 1(203) 0.62 [0.28, 1.38] NA 0.24 
• NRCT 32.8% 47.7% 84 2(146) 0.67 [0.44, 1.03] 0% 0.07 
In-patients        
• RCT 8.7% 11.0% 238 1(203) 0.79 [0.34, 1.83] NA 0.59 
1 month        
• RCT NR NR  NR NR NR NR 
• NRCT 12.1% 25.0% 84 2(146) 0.48 [0.22, 1.05] 0% 0.07 
3 months        
• RCT 8.7% 14.0% 238 1(203) 0.62 [0.28, 1.38] NA 0.24 
6 months        
• RCT NR NR  NR NR NR NR 
• NRCT 32.8% 47.7% 84 2(146) 0.67 [0.44, 1.03] 0% 0.07 
Pneumonia        
• Overall 8.7% 13.9% 84, 238-242 7(2110) 0.39 [0.17, 0.91] 53% 0.03 
• RCT 0.6% 5.6% 238-240 3(284) 0.14 [0.02, 1.11] NA 0.06 
• NRCT 10.0% 15.2% 84, 241, 242 4(1826) 0.47 [0.21, 1.06] 51% 0.07 
Tube feeding        
• Overall 18.1% 29.1% 84, 237, 242 4(1853) 0.62 [0.48, 0.79] 36% 0.0001 
• RCT 41.4% 100.0% 84, 237, 242 1 (51) 0.43 [0.28, 0.65] NA < 0.0001 
• NRCT 17.5% 27.2% 84, 242 3 
(1802) 
0.68 [0.57, 0.81] 0% < 0.0001 
Length of stay        
• RCT NR NR  NR NR NR NR 
• NRCT 11.79.7 16.87.6 84, 243 2(200) -3.21 [-5.26, -
1.16] 
0% 0.002 
• Oral Health        





       






    
 
  




I2: Heterogeneity; MD: Mean difference; n: Number of studies; N: Number of patients; RR: Risk ratio;  
p: Statistical significance value  
  
Table 14: Effect of different pharmaceutical agents on key outcomes 
 
Outcome Incidence % Studies n (N) RR [95% CI], 
MD [95% CI] 
I2 P value 
Drugs Control 
Mortality        
ACE inhibitors        
• Overall 10.3% 10.5% 257, 258, 
268, 275 
4(6733) 0.96 [0.54, 
1.69] 
75% 0.88 
• RCTs: vs Control 10.6% 11.0% 257, 258, 268 3(6244) 0.97 [0.46, 
2.04] 
83% 0.93 
• NRCT: vs Control 4.8% 5.6% 275 1(489) 0.86 [0.37, 
1.99] 
NA 0.72 





15.2% 42.9% 257 1(68) 0.35 [0.14, 
0.86] 
NA 0.02 
Antibiotics: RCTs 16.1% 15.3% 250, 252, 
255, 256, 
263, 264, 266 
7(4301) 1.05 [0.87, 
1.26] 
16% 0.61 
Metoclopramide: RCT 26.7% 40.0% 265 1(60) 0.67 [0.32, 
1.39] 
NA 0.28 
Pneumonia        
ACE inhibitors        

























• NRCTs vs control 3.6% 11.4% 271, 274, 
275, 278 
4(1491) 0.41 [0.26, 
0.64] 
0% < 0.0001 
• NRCTs: vs other 
antihypertensive 
drugs 




TRPV-agonists        
• Overall 9.6% 32.7% 254, 277 2(104) 0.31 [0.15, 
0.66] 
0% 0.002 
• RCT: Vs Control 0.0% 2.9% 254 1(70) 0.33 [0.01, 
7.91] 
NA 0.50 





6.0% 27.5% 259 1(163) 0.22 [0.09, 
0.55] 
NA 0.001 
Antibiotics: RCTs 10.3% 11.1% 252, 255, 
256, 263, 
264, 266 
6(4201) 0.93 [0.78, 
1.10] 
17% 0.40 
Outcome Incidence % Studies n (N) RR [95% CI], 
MD [95% CI] 
I2 P value 
Drugs Control 
Metoclopramide: RCT 26.7% 86.7% 265 1(60) 0.31 [0.17, 
0.57] 
NA 0.0002 
        
mRS        
Antibiotics: RCTs        
• mRS 0-2 46.0% 45.4% 250, 256, 
264, 266 
3(3946) 1.02 [0.83, 
1.25] 
56%  0.85 
• mRS 3-6 43.3% 45.4% 263, 264, 266 3(2825) 0.97 [0.91, 
1.02] 
31% 0.25 
        
Length of stay in 
hospital, days 
       
• ACE inhibitor: RCT 3722 5136 257 1(68) -14.00 [-
28.09, 0.09] 
NA 0.05 
• Dopaminergic: RCT 3722 5136 257 1(68) -14.00 [-
28.09, 0.09] 
NA 0.05 
• Antibiotics: RCT 12.55.9 10.25.8 256, 266 2(3755) 3.49 [-3.37, 
10.35] 
100% 0.32 
Aspiration        





25.9% 91.7% 269 1(39) 0.30 [0.16, 
0.58] 
0% 0.0003 
Latency of swallowing 
reflex 
       
• TRPV agonist        
• Change        
• Overall -7.41.2 -0.57.2 253, 254, 276 3(174) -5.14 [-7.86, 
-2.41] 
100% 0.80 
• RCT -7.91.5 -0.69.4 253, 254 2(134) -6.68 [-
15.75, 2.39] 
90% 0.15 






       




closure time, sec 
       
• TRPV agonist 0.30.0 0.40.0 121, 262 3(116) -0.10 [-0.12, 
-0.08] 
70% <0.00001 
Hyoid bone maximum 
anterior extension 
time, sec 
       
Outcome Incidence % Studies n (N) RR [95% CI], 
MD [95% CI] 
I2 P value 
Drugs Control 
• TRPV agonist 0.50.0 0.60.1 121, 262 3(146) -0.15 [-0.16, 
-0.13] 
0% <0.00001 
Latency of Swallowing 
reflex  
       
• Dopaminergic 
drugs: RCT 
2.90.8 8.31.2 270 1(54) -5.40 [-5.94, 
-4.86] 
NA <0.00001 
Swallows/min        
• TRPV agonist        




ACE: Angiotensin converting enzyme; CI: Confidence intervals; I2, p: Heterogeneity; n: Number of 
studies; N: Number of patients; MD: Mean difference;NA: Not applicable; NRCT: Non-Randomized 
Controlled Trial; p: Statistical significance value; RCT: Randomized Controlled Trial; RR: Risk ratio; 
TRPV: transient receptor potential vanilloid 
  
Table 15: Effect of different neurostimulation modalities on key outcomes 
 
Outcome MeanSD Studies n (N) RR [95% CI]/ 
(S)MD [95% 
CI] 




    
 
  
TES        
• Overall 5.82.7 3.52.6 173, 282, 284, 
287, 294-296, 







• RCT 6.22.8 3.72.7 173, 282, 284, 
287, 294-296, 
299, 301, 304, 





• NRCT 3.71.9 1.81.9 316, 317, 319 3(122) 1.14 [-0.13, 
2.41] 
78% 0.08 
rTMS        
• Overall 9.66.1 4.75.1  11(236) 1.33 [0.51, 
2.16] 
85% 0.002 
• RCT 10.56.4 5.35.5 285, 289-291, 
295, 297, 298, 300 
10(212) 1.51 [0.60, 
2.42] 
85% 0.001 
• NRCT 0.82.6 0.72.5 318 1(24) 0.04 [-0.76, 
0.84] 
NA 0.93 
tDCS        
• Overall 2.82.3 2.01.8 281, 292, 293, 
303, 306, 310 
8(196) 0.75 [0.38, 
1.12] 
26% <0.0001 
• RCT 2.82.3 2.01.8 281, 292, 293, 
303, 306, 310 





    
 
  
• Overall 2.31.9 1.62.2 283, 288, 297, 
302, 309 




2.31.9 1.62.2 283, 288, 297, 
302, 309 
5(204) 0.77 [-0.06, 
1.60] 
80% 0.07 
PES, tracheostomised        




5.63.9 5.24.3 286, 305 2(83) 0.25 [-0.19, 
0.69] 
0% 0.27 
Mortality, RCT        
• 2 weeks, PES 3.5% 1.5% 283, 288 2(154) 1.66 [0.22, 
12.37] 
0% 0.62 
• 3 months, PES 13.8% 12.0% 283, 288, 309 3(231) 1.10 [0.55, 
2.18] 
0% 0.78 
mRS, RCT        
• rTMS 1.0±0.7 2.5±1.3 285 1(38) -1.50 [-2.29, -
0.71] 
0% 0.0002 
• PES 3.8±1.1 4.2±1.0 283, 286 2(177) -0.33 [-0.63, -
0.02] 
0% 0.04 


















1.52] 0% 0.33 
BI        








• rTMS, NRCT 64.020.0 70.020.0 318 1(24) -6.00 [-22.00, 
10.00] 
NA 0.46 
• PES, RCT 36.130.5 27.025.7 283, 288 2(154) -0.34 [-1.19, 
0.51] 
74% 0.43 
LOS, Hospital (d), RCT        
• tDCS 16.26.8 13.45.1 306 1(59) 2.80 [-0.28, 
5.88] 
NA 0.07 
• PES 32.420.7 35.322.1 283, 305 3(192) -4.23 [-12.11, 
3.66] 
33% 0.29 
LOS, ICU (d), RCT        
• tDCS 6.74.4 7.03.3 306 1(59) -0.30 [-2.29, 
1.69] 
NA 0.77 
• PES 38.214.9 38.819.7 306 1(59) -0.60 [-14.45, 
13.25] 
NA 0.93 




59.0% 7.5% 286, 305, 320 3(145) 5.43 [2.42, 
12.16] 
0% < 0.0001 
• Tracheotomised 
patients, PES, RCT 






60.9% 0.0% 320 1(46) 29.00 [1.83, 
459.04] 
NA 0.02 
Feeding Tube removal        
• TES, RCT 50.0% 14.3% 294 1(19) 3.50 [0.52, 
23.42] 
NA 0.2 
• PES, RCT 50.0% 28.6% 309 1(30) 1.75 [0.67, 
4.58] 
NA 0.25 
Quality of Life, change 
from baseline, RCT 
       
• Swallowing QoL, 
TES 
26.218.2 7.217.1 304, 312 3(106) 18.02 [11.41, 
24.63] 
37% <0.00001 
CI: Confidence intervals; tDCS: transcranial Direct Current Stimulation; I2: Heterogeneity; n: 
Number of studies; N: Number of patients; TES: Transcutaneous Electrical Stimulation; NRCT: 
RCT: Non-randomized controlled trial (Cohort, before after, case-control studies); p: 
Statistical significance value; PES: Pharyngeal Electrical Stimulation; RCT: Randomized 
controlled trial; RR: Risk ratio SD: Standard Deviation; SMD: Standard Mean Difference; 
rTMS: repetitive Transcranial Magnetic Stimulation; BI: Barthel Index; LOS: Length of stay; 
ICU: Intensive care unit 
  
Box 1. Grades of quality of evidence. 
 
Grade Definition Symbol 
High Further research is very unlikely to change our confidence 
in the estimate of effect. 
⊕⊕⊕⊕ 
Moderate Further research is likely to have an important impact on 
our confidence in the estimate of effect and may change 
the estimate. 
⊕⊕⊕ 
Low Further research is very likely to have an important impact 
on our confidence in the estimate of effect and is likely to 
change the estimate. 
⊕⊕ 
Very low We are very uncertain about the estimate. ⊕ 
 




Strong for an 
intervention 
 
The desirable effects of an intervention clearly 
outweigh its undesirable effects. 
 
 
Weak for an 
intervention 
. 
The desirable effects of an intervention probably 
outweigh the undesirable effects 
? 
Weak against an 
intervention 
 
The undesirable effects of  an intervention probably 
outweigh the desirable effects 
↓? 
Strong against an 
intervention 
 
The undesirable effects of an intervention clearly 
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